Skip to main content
Clinical Trials/EUCTR2004-004835-72-GB
EUCTR2004-004835-72-GB
Active, not recruiting
Not Applicable

A study to determine the effects of growth hormone (GH) replacement therapy on quality of life and cardiovascualr risk in GH deficient adults - Growth Hormone and Quality of Life (GroH-QoL)

niversity of Birmingham0 sites200 target enrollmentFebruary 17, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Birmingham
Enrollment
200
Status
Active, not recruiting
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 17, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged over 18
  • Able to provide informed consent
  • Severe GH deficiency in adult life
  • No GH replacement for six months
  • Other hormone therapy stable over preceding six months
  • Life expectancy \> 15 months
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • Active malignant disease
  • Active Cushing's disease or active acromegaly
  • Breast feeding
  • Proliferative diabetic retinopathy
  • Sensitivity to GH or it preservative

Outcomes

Primary Outcomes

Not specified

Similar Trials